ArticleJPGN reports2026

Preliminary evidence of improved liver biomarkers in adolescents with obesity and suspected metabolic dysfunction-associated steatotic liver disease treated with semaglutide: A case series.

Rachel Schenker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.